• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Negative associations of age and lifestyle factors with the antibody response to the COVID-19 vaccine BNT162b2 in health workers fr

tetano

Editor, Senior Moderator
Front Immunol


. 2025 May 30:16:1590939.
doi: 10.3389/fimmu.2025.1590939. eCollection 2025. Negative associations of age and lifestyle factors with the antibody response to the COVID-19 vaccine BNT162b2 in health workers from Spain

Luis Sarabia de Ardanaz[SUP] 1 2 [/SUP], Esther Serrano-Conde[SUP] 3 [/SUP], Ana Fuentes[SUP] 3 4 5 [/SUP], Alba Leyva[SUP] 6 [/SUP], Federico García[SUP] 3 4 5 [/SUP], Pilar Requena[SUP] 1 4 7 [/SUP]



Affiliations
Abstract

Introduction: Despite the high efficacy of the anti-coronavirus disease 2019 (COVID-19) BNT162b2 vaccine (Comirnaty[SUP]®[/SUP], Pfizer-BioNTech), variability in the antibody titers following vaccination has been described. However, little is known about the risk factors that are associated with a poorer antibody response to the BNT162b2 vaccine.
Methodology: We studied the determinants of the humoral response to the anti-COVID-19 vaccine BNT162b2 in 200 healthcare workers followed up for 2 years. Serum samples were tested for the anti-spike immunoglobulin G (IgG) levels and neutralizing antibody titers against selected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants at different time points after primary and booster vaccinations. Anthropometric data and clinical and lifestyle information were also collected. Statistical analyses consisted of linear and logistical regressions for point estimations and the Mann-Whitney, Friedman, and generalized estimating equations for repeated measures.
Results: After the primary vaccination, the antibody titers and the percentage of seroconverted individuals peaked at 5 weeks but declined after 1 year; however, they remained high after the booster administration. After the first dose of the vaccine, negative associations of the anti-spike IgG levels with age (β = -0.01, 95%CI = -0.03 to -0.003), smoking habit (β = -1.08, 95%CI = -1.70 to -0.46), and alcohol consumption (β = -1.43, 95%CI = -2.20 to -0.65) were found. With regard to the booster vaccine, the following associations were retained in the stepwise multivariate model: anti-Delta neutralizing antibodies with hip circumference (OR = 1.07, 95%CI = 1.01-1.12, p = 0.008), anti-Delta-K antibodies with hip circumference (OR = 1.06, 95%CI = 1.01-1.11, p = 0.007), and anti-Omicron antibodies with the Mediterranean diet score (OR = 0.74, 95%CI = 0.58-0.96, p = 0.023).
Conclusion: Lifestyle habits and age had an association with the humoral response to the BNT162b2 vaccine.

Keywords: BNT162b2; COVID-19; SARS-CoV-2; anti-spike IgG; neutralizing antibodies; vaccines.

 
Back
Top Bottom